Literature DB >> 29330632

Inate immunity in rosacea. Langerhans cells, plasmacytoid dentritic cells, Toll-like receptors and inducible oxide nitric synthase (iNOS) expression in skin specimens: case-control study.

Ana Karina Alves Moura1, Fernanda Guedes2, Maria Cecília Rivitti-Machado2, Mirian N Sotto2.   

Abstract

Rosacea is a chronic inflammatory condition with predominant facial involvement. Because of that, many patients sense that rosacea affects quality of life. The etiology of rosacea remains unknown. Recent studies have suggested that aberrant innate immunity is central to this disease. The aim of this study was to examine the presence of Langerhans cells, plasmacytoid dentritic cells (PDC), the expression of Toll-like receptors (TLR) and inducible oxide nitric synthase (iNOS) in skin of patients with rosacea, to highlight the participation of innate immunity in its pathogenesis. 28 biopsy specimens were taken from patients with clinical and histopathological findings of rosacea. Immunohistochemical demonstration of Langerhans cells (anti-CD1a antibody), PDC (anti-CD 123 antibody), TLR2, TLR4 and iNOS was performed in skin samples and compared with normal skin controls. The expression of Langerhans cells was lower in rosacea group than in control group. PDC were found in skin samples of rosacea as isolated cells and forming small clusters. Expression of TLR2, TLR4 and iNOS was higher in rosacea samples than in normal skin controls. This research demonstrates early and late stage components of innate immunity in specimens of rosacea ratifying the existence of an altered innate immunity in its pathogenesis.

Entities:  

Keywords:  Inducible oxide nitric synthase; Innate immunity; Langerhans cells; Plasmacytoid dentritic cells; Rosacea; Toll-like receptors

Mesh:

Substances:

Year:  2018        PMID: 29330632     DOI: 10.1007/s00403-018-1806-z

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  5 in total

1.  Hydroxocobalamin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.

Authors:  Yi-Wei Huang; Hui-Peng Huang; Chao-Kai Hsu; Julia Yu-Yun Lee
Journal:  J Clin Aesthet Dermatol       Date:  2022-06

Review 2.  Recent advances on endogenous gasotransmitters in inflammatory dermatological disorders.

Authors:  Lian Wang; Xin Xie; Bowen Ke; Wei Huang; Xian Jiang; Gu He
Journal:  J Adv Res       Date:  2021-09-01       Impact factor: 12.822

Review 3.  Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.

Authors:  Daniela Rodrigues-Braz; Min Zhao; Nilufer Yesilirmak; Selim Aractingi; Francine Behar-Cohen; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2021-05-13       Impact factor: 2.367

4.  MMP-9 Levels in the Gingival Crevicular Fluid of Chilean Rosacea Patients.

Authors:  Javier Fernández; Constanza Jiménez; Dafna Benadof; Paulina Morales; Jessica Astorga; Felipe Cáceres; Marcela Hernández; Alejandra Fernández; Fernando Valenzuela
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

5.  A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.

Authors:  Jiawen Zhang; Peiyu Jiang; Lei Sheng; Yunyi Liu; Yixuan Liu; Min Li; Meng Tao; Liang Hu; Xiaoyan Wang; Yanjing Yang; Yang Xu; Wentao Liu
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.